1. <b id="ectad"></b>

      <input id="ectad"></input>

      1. <source id="ectad"></source>
        <u id="ectad"></u>

          1. <sub id="ectad"></sub>
              <b id="ectad"></b>

                1. <u id="ectad"></u>
                  <sub id="ectad"></sub>
                  <wbr id="ectad"></wbr>

                  1. <video id="ectad"></video>

                      <small id="ectad"></small>
                      <sub id="ectad"></sub>
                      Chengdu's HitGen to Collaborate with Global Blood Therapeutics
                      Author:Yestar      Time:2016-01-12
                      HitGen Ltd, a Chengdu CRO specializing in drug discovery, formed a research collaboration with Global Blood Therapeutics of the US, a clinical-stage biopharma focused on therapeutics for blood-based disorders. HitGen will provide biology, chemistry, and screening on an undisclosed novel GBT target. GBT's lead molecule is a clinical-stage drug candidate that treats the underlying mechanism of sickle cell disease, which was recently granted Orphan Drug designation in the US.
                      0

                      Copyright ? 2017 Yestar Healthcare Holdings Company Limited     Powered By : Yestarcorp    沪ICP备10207132号-5

                        沪公网安备 31011202004160号
                      国产成人av电影在线观看第一页